Detalles de la búsqueda
1.
High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
J Gen Virol
; 98(7): 1713-1719, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28708052
2.
Association between vitamin D receptor gene polymorphisms and fibrosis susceptibility in Greek patients with HCV infection.
Germs
; 12(3): 384-393, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37680672
3.
HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks.
Aliment Pharmacol Ther
; 56(4): 702-712, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736010
4.
Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis, before and after Treatment with Direct Antiviral Agents: A pilot Study.
Maedica (Bucur)
; 15(2): 162-168, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32952679
5.
Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study.
Ann Gastroenterol
; 33(1): 87-94, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892803
6.
Relationship between antibodies to hepatitis C virus core+1 protein and treatment outcome.
Ann Gastroenterol
; 31(5): 593-597, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30174396
7.
Should active injecting drug users receive treatment for chronic hepatitis C?
Arq Gastroenterol
; 47(3): 238-41, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21140082
8.
Should active injecting drug users receive treatment for chronic hepatitis C? / Usuários ativos de drogas injetáveis devem receber tratamento para hepatite crônica tipo C?
Arq. gastroenterol
; 47(3): 238-241, jul.-set. 2010. ilus, tab
Artículo
en Inglés
| LILACS | ID: lil-567302
Resultados
1 -
8
de 8
1
Próxima >
>>